Yi, L., Pan, H., Ning, Z., Xu, L., Zhang, H., Peng, L., . . . Xie, J. Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: A phase II trial. Nature Publishing Group.
Chicago Style (17th ed.) CitationYi, Lixia, et al. Clinical and Biomarker Analyses of SHR-1701 Combined with Famitinib in Patients with Previously Treated Advanced Biliary Tract Cancer or Pancreatic Ductal Adenocarcinoma: A Phase II Trial. Nature Publishing Group.
MLA (9th ed.) CitationYi, Lixia, et al. Clinical and Biomarker Analyses of SHR-1701 Combined with Famitinib in Patients with Previously Treated Advanced Biliary Tract Cancer or Pancreatic Ductal Adenocarcinoma: A Phase II Trial. Nature Publishing Group.